SEC Form 4
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) insider trading
In the 12 months to Oct 26, 2026, one DHCNL insider reported open-market purchases of $97.7K across 1 filing; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $97.7K
- 1 filing · Christopher J. Bilotto, President and CEO
Who traded DHCNL, and when
- Purchase
DHCNL daily close from Oct 27, 2025 to Oct 26, 2026, between $17.12 and $19.82, last $18.14. 0 sale and 1 purchase filings by 1 insider, marked at their filing dates. Christopher J. Bilotto, President and CEO: bought $97.7K across 1 filing, first filed Dec 16, 2025, last Dec 16, 2025.
Largest mark · tap a row for others
Christopher J. Bilotto · President and CEO
Purchase $97,720
20,000 shares at $4.89 avg
Filed Dec 16, 2025 · traded Dec 15
Close on filing date $17.64
Christopher J. Bilotto · President and CEO
President and CEO
$97.7K boughtOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Christopher J. Bilotto | President and CEO | — | $97.7K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Christopher J. Bilotto President and CEO | Purchase | 20,000 | $4.89 | $97.7K | 266,285 |
GET /stocks/filings/vX/form-4?tickers=DHCNL&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"DHC",
"DHCNI",
"DHCNL"
],
"issuer_cik": "0001075415",
"owner_cik": "0001806557",
"accession_number": "0001104659-25-121626",
"form_type": "4",
"filing_date": "2025-12-16",
"period_of_report": "2025-12-15",
"issuer_name": "DIVERSIFIED HEALTHCARE TRUST",
"issuer_trading_symbol": "NASDAQ:DHC",
"owner_name": "Bilotto Christopher J.",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "President and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Shares of Beneficial Interest",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2025-12-15",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 20000,
"transaction_price_per_share": 4.886,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 266284.908,
"transaction_value": 97720,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.88 to $4.89 per share. Mr. Bilotto undertakes to provide to Diversified Healthcare Trust (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."
},
{
"id": "F2",
"description": "Includes 385.018 shares acquired under a dividend reinvestment plan since the last Section 16 filing by Mr. Bilotto."
}
]
}
]
}
// trimmed to 1 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 13 records
- Tax withholding3 records
- Grants and awards10 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Diversified Healthcare Trust 6.25% Senior Notes Due 2046's CEO sold stock?
No. Christopher J. Bilotto (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is DHCNL’s insider data?
These are DHCNL Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track DHCNL insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for DHCNL every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.